According to Organovo's latest financial reports the company's current revenue (TTM) is $0.24 M. In 2022 the company made a revenue of $1.7 M an increase over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.24 M | -85.83% |
2022 | $1.7 M | |
2021 | N/A | |
2020 | N/A | -100% |
2019 | $2.87 M | -18.2% |
2018 | $3.51 M | -18.42% |
2017 | $4.31 M | 8.67% |
2016 | $3.96 M | 229.95% |
2015 | $1.2 M | 186.87% |
2014 | $0.41 M | -12.53% |
2013 | $0.47 M | -59.98% |
2012 | $1.19 M | 71277.46% |
2011 | $0 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
General Electric GE | $69.52 B | 28,727,172.73% | ๐บ๐ธ USA |
3M MMM | $32.65 B | 13,492,875.21% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | $7.31 B | 3,024,073.55% | ๐บ๐ธ USA |
United Therapeutics UTHR | $2.49 B | 1,032,255.37% | ๐บ๐ธ USA |
Stratasys SSYS | $0.62 B | 259,238.02% | ๐ฎ๐ฑ Israel |
3D Systems DDD | $0.50 B | 208,971.49% | ๐บ๐ธ USA |